Business Update Neutral

2026-08-26 17:19

- Investor Meeting Schedule - Meeting Date: August 31, 2026 - Investor/Analyst: ITUS Capital - Type: One-on-One, Virtual - No unpublished price sensitive information (UPSI) will be shared.

Business Update Neutral

2026-08-19 17:47

- Investor Meetings Schedule - August 25, 2026: Meeting with Kotak Mahindra Asset Management Company (Virtual, One-on-One) - August 31, 2026: Meeting with Quest Investments (Mumbai, One-on-One) - September 04, 2026: Meeting with Awriga Capital (Mumbai, One-on-One) - No unpublished price sensitive information will be shared during these interactions.

Business Update Neutral

2026-08-19 17:45

- Investor/Analyst Meetings Scheduled: - August 25, 2026: Virtual one-on-one meeting with Kotak Mahindra Asset Management Company. - August 31, 2026: One-on-one meeting in Mumbai with Quest Investments. - September 04, 2026: One-on-one meeting in Mumbai with Awriga Capital. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-19 17:44

- Intimation for interaction with Analysts/Investor(s) - Meetings scheduled: - August 25, 2026: Kotak Mahindra Asset Management Company (Virtual, One-on-One) - August 31, 2026: Quest Investments (Mumbai, One-on-One) - September 04, 2026: Awriga Capital (Mumbai, One-on-One) - No unpublished price sensitive information will be shared.

Business Update Positive

2026-08-18 20:45

- Q1 FY27 Reported Revenue: ₹17,023 million with a gross margin of 57% and EBITDA margin of 22%. - Domestic agri business achieved 12% volume growth in Q1 FY27, including 50% growth in biologicals, leading to 3% revenue growth despite initial market challenges. - FY27 Outlook: Expects FY27 to be better than FY26, driven by H2 export recovery, new product launches, and scale-up in pharma and global biologicals businesses. Revenue growth projected in the "lower single digit" positive trajectory. - Strategic Investments: Significant R&D investments (3-4% of revenue) and capital expenditure (FY27 guidance ₹700-800 crore) for new verticals, innovation, and existing manufacturing. - Growth Initiatives: Expanding global biologicals, launching unique foliar application nematicide in Brazil, Mexico, and US. First NCE, Pioxaniliprole (insecticide), expected for domestic launch soon, with 4-5 new molecule launches planned for FY27 across various segments. - Financial Strength: Strong debt-free balance sheet with ₹38 billion net cash; reduced net working capital by 19 days, releasing ₹300 crore cash. - Margin Management: Facing margin pressure from high input costs and inventory but focused on optimization to maintain targeted gross margins.

Governance Neutral

2026-08-14 18:16

CRITICAL RED FLAG DETECTED

- PI Industries' 79th AGM held August 14, 2026. - All 9 business items passed, including FY2025-26 financials and ₹15/share dividend. - Joint MD Rajnish Sarna stepped down; Non-Executive Director Arvind Singhal not re-appointed. - Management confident in future growth and industry recovery.

Business Update Neutral

2026-08-13 18:32

- Investor Interactions Schedule - August 19, 2026: One-on-One meeting with DSP Asset Managers (Mumbai) - August 24, 2026: One-on-One virtual meeting with Capital World - No unpublished price sensitive information to be shared during these interactions.

Business Update Neutral

2026-08-13 18:31

- PI Industries Limited will interact with analysts/investors on August 19, 2026 (DSP Asset Managers in Mumbai) and August 24, 2026 (Capital World virtually). - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-12 16:50

- Concall Schedule - Concall Date: August 19, 2026

Business Update Neutral

2026-08-12 16:41

- Audio recording of the Earnings Conference Call for the quarter ended June 30, 2026, is now available. It discusses the unaudited standalone & consolidated financial results. The call was held on August 12, 2026, and the recording is accessible on the company's website.

Financials Negative

2026-08-11 21:22

- Q1 FY27 Consolidated Revenue ₹17,023 Mn vs ₹19,005 Mn (▼10% YoY) - EBITDA ₹3,693 Mn vs ₹5,219 Mn (▼29% YoY) - PAT ₹2,442 Mn vs ₹4,000 Mn (▼39% YoY) - EBITDA Margin 22% vs 27% (▼577bps)

Financials Negative

2026-08-11 19:36

- Q1 FY27 Consolidated Revenue ₹17,023Mn vs ₹19,005Mn (▼10.43% YoY) - EBITDA ₹3,693Mn vs ₹5,219Mn (▼29.24% YoY) - PAT ₹2,442Mn vs ₹4,000Mn (▼38.95% YoY) - EBITDA Margin 21.69% vs 27.46% (▼577bps) - The Board also approved the incorporation of a Wholly Owned Subsidiary, 'PI Foundation', under Section 8 of the Companies Act, 2013.

Financials Negative

2026-08-11 19:16

- Q1 FY27 Consolidated Revenue ₹17,023Mn vs ₹19,005Mn (▼10.42% YoY) - EBITDA ₹4,334Mn vs ₹6,078Mn (▼28.69% YoY) - PAT ₹2,442Mn vs ₹4,000Mn (▼38.95% YoY) - EBITDA Margin 25.46% vs 31.98% (▼652bps) - Board approved the incorporation of PI Foundation as a wholly-owned subsidiary for CSR activities, with an initial share capital of ₹1,00,000/-.

Business Update Neutral

2026-08-03 19:17

- Concall Schedule - Concall Date: August 12, 2026 - Concall Time: 12:00 noon IST

Governance Neutral

2026-07-21 17:45

- Intimation regarding the 79th Annual General Meeting (AGM). - AGM scheduled for August 14, 2026, at 10:30 A.M. (IST) via VC/OAVM. - Web-links for the AGM notice and FY 2025-26 Integrated Annual Report shared with shareholders.

Governance Positive

2026-07-20 15:26

- Submission of Integrated Annual Report for FY 2025-26 and Notice for 79th Annual General Meeting (AGM). - AGM scheduled for August 14, 2026, at 10:30 a.m. (IST) via Video Conferencing. - Record date for dividend entitlement is August 7, 2026. - Proposed final dividend of Rs. 10/- per equity share for FY 2025-26, if declared at the AGM.

Governance Positive

2026-07-16 19:46

- 79th Annual General Meeting (AGM) scheduled for August 14, 2026. - Record Date for final dividend of ₹10/- per equity share for FY 2025-26 (if declared) is August 7, 2026.

Governance Positive

2026-07-16 19:11

- Intimation of 79th AGM on August 14, 2026, through VC/OAVM. - Record Date for final dividend of Rs. 10/- per equity share for FY 2025-26 is August 7, 2026, if declared at AGM.

Routine Neutral

2026-06-26 15:00

- The trading window for dealing in the Company's securities will remain closed for all Designated Persons and their immediate relatives from July 1, 2026. - It will reopen 48 hours after the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026, are made public.

Business Update Positive

2026-06-23 19:46

- PI Industries' Board approved converting ₹10,000 Cr worth of Optionally Fully Convertible Debentures (OFCDs) held in its wholly-owned subsidiary, PI Health Sciences Limited (PIHS), into 72,46,37,681 equity shares. This strengthens the consolidated balance sheet without changing PIHS's ownership or control.

Business Update Neutral

2026-06-18 16:20

- PI Industries Limited announced interactions with analysts and investors. - Meetings scheduled for June 23, 2026, with Ellerston Capital (Virtual) and JM Financial Institutional Securities (Mumbai). - Additional investor meetings are scheduled for June 25 and June 26, 2026, in Singapore. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-06-18 16:17

- PI Industries Limited will interact with analysts/investors on June 23, 2026, and June 25-26, 2026. - Meetings include Ellerston Capital, JM Financial Institutional Securities, and general investor meetings in Virtual, Mumbai, and Singapore. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-06-18 16:13

- PI Industries Limited will interact with analysts/investors on June 23, 2026, including Ellerston Capital (Virtual) and JM Financial Institutional Securities (Mumbai). - Further investor meetings are scheduled in Singapore on June 25 and June 26, 2026. - No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-06-16 17:57

- Schedule of Investor/Analyst Interactions - Date: June 22, 2026 - Interactions with: Enam AMC, ADD Capital, Capital Group (London), Franklin Templeton MF (all one-on-one) - No Unpublished Price Sensitive Information (UPSI) will be shared.

Business Update Neutral

2026-06-11 13:19

- Investor/Analyst Meetings Schedule - Date: June 16, 2026 - Company representatives to interact with Nuvama Institutional Equities and Keynote Financial Services Ltd in one-on-one meetings.

Business Update Neutral

2026-06-02 15:53

- Investor/Analyst Meetings Schedule - June 5, 2026: One-on-One meeting with Morgan Stanley in Mumbai. - June 12, 2026: One-on-One meeting with Bank of America Securities in Mumbai. - No Unpublished Price Sensitive Information (UPSI) will be shared.

Business Update Neutral

2026-06-02 15:49

- Investor Interactions Scheduled - June 5, 2026: One-on-One meeting with Morgan Stanley - June 12, 2026: One-on-One meeting with Bank of America Securities

Business Update Neutral

2026-05-26 16:29

PI Industries Limited announced one-on-one meetings with Matthews International Capital Management, ICICI Prudential Asset Management Company, and ithought PMS on May 31, June 01, and June 09, 2026, respectively, in Mumbai. No unpublished price sensitive information will be shared during these interactions.

Business Update Neutral

2026-05-26 16:26

PI Industries Limited announced one-on-one interactions with institutional investors and broking houses, including Matthews International Capital Management, ICICI Prudential Asset Management Company, and ithought PMS. These meetings are scheduled for May 31, June 01, and June 09, 2026, in Mumbai. The company confirmed that no unpublished price sensitive information will be shared during these interactions.

Business Update Neutral

2026-05-26 16:24

PI Industries Limited will interact with analysts/investors from Matthews International Capital Management, ICICI Prudential Asset Management Company, and ithought PMS via one-on-one meetings on May 31, 2026, June 01, 2026, and June 09, 2026, respectively. The company has stated that no unpublished price sensitive information will be shared during these meetings.

Business Update Positive

2026-05-26 13:09

Management guided for positive revenue growth in FY27, expecting late single-digit to early double-digit growth even in a worst-case scenario. This growth is anticipated to be driven by a recovery in exports, new product launches (including their first homegrown New Chemical Entity, Pioxaniliprole), and the scaling up of Pharma and Biologicals businesses. The Pharma segment is expected to achieve INR 500-600 crore revenue and turn EBITDA positive in 2-3 years, while Electronic Chemicals target ~$100 million revenue in 4-5 years. FY27 capex is guided at INR 700-800 crore. Despite the current global agrochemical downcycle and Q4 FY26 margin compression, the company maintained healthy FY26 consolidated EBITDA margins of 25% and remains debt-free with substantial cash, focusing on long-term innovation and diversification.

Business Update Neutral

2026-05-25 12:52

PI Industries Limited informed about upcoming interactions with analysts and investors. The company will participate in the Axis Capital Rising Stars Conference 2026 on June 1, 2026, and Citi's 2026 India Conference on June 5, 2026, both to be held at Grand Hyatt, Mumbai. The meetings will include a mix of one-on-one and group interactions. No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-05-25 12:50

PI Industries Limited will interact with analysts and investors at two upcoming events: the Axis Capital Rising Stars Conference 2026 on June 1, 2026, and Citi's 2026 India Conference on June 5, 2026. Both events will be held at Grand Hyatt, Mumbai, involving a mix of one-on-one and group meetings. No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-05-21 18:32

PI Industries Limited announced an interaction with Analysts/Investors. The company will hold a virtual one-on-one meeting with Blackrock Asset on May 26, 2026. No unpublished price sensitive information is proposed to be shared during the meeting.

Business Update Neutral

2026-05-20 17:54

PI Industries Limited announced the availability of the audio recording of its Earnings Conference Call with Analysts and Investors. The call, held on May 20, 2026, discussed the Audited Standalone & Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The recording is available on the company's website.

Financials Negative

2026-05-19 22:36

CRITICAL RED FLAG DETECTED

Standalone Revenue ₹13,914Mn vs ₹16,482Mn (▼15.6% YoY), EBITDA ₹4,563Mn vs ₹5,721Mn (▼20.2% YoY), PAT ₹1,978Mn vs ₹3,858Mn (▼48.7% YoY). EBITDA Margin 32.8% vs 34.7% (▼190bps). The Board recommended a final dividend of ₹10/- per share, making the total dividend for FY26 ₹15/- per share. The filing also noted the resignation of the Joint Managing Director and a significant impairment loss of ₹1,100Mn on an equity investment.

Governance Neutral

2026-05-19 22:16

PI Industries Limited announced on May 19, 2026, the authorization of three Key Managerial Personnel (KMP) by the Board under Regulation 30(5) of SEBI Listing Regulations. Dr. Atul Kumar Gupta (Whole-Time Director), Mr. Sanjay Agarwal (Group Chief Financial Officer), and Ms. Shruti Joshi (Company Secretary & Compliance Officer) are empowered to determine the materiality of events and make disclosures to stock exchanges.

Governance Negative

2026-05-19 21:39

CRITICAL RED FLAG DETECTED

The Board of Directors of PI Industries Limited, at its meeting on May 19, 2026, approved the standalone financial results for the quarter and financial year ended March 31, 2026, and recommended a final dividend of ₹10/- per share. Standalone Q4 FY26 revenue declined by 15.6% YoY to ₹13,914 million, and PAT fell by 48.7% YoY to ₹1,978 million. Full-year standalone revenue decreased by 18.3% YoY and PAT by 23.1% YoY. Mr. Rajnish Sarna resigned as Joint Managing Director but was re-designated as Non-Executive, Non-Independent Director. The company also recognized an ₹1,100 million impairment loss on an equity investment.

Governance Negative

2026-05-19 21:39

CRITICAL RED FLAG DETECTED

The Board of Directors of PI Industries Limited, in its meeting on May 19, 2026, approved the standalone & consolidated financial results for the quarter and financial year ended March 31, 2026, and recommended a final dividend of ₹10/- per share, making the total dividend for FY26 ₹15/- per share. Key governance changes include the resignation of Mr. Rajnish Sarna as Joint Managing Director (though re-designated as Non-Executive, Non-Independent Director) and Mr. Arvind Singhal not seeking re-appointment. Several other director appointments and re-appointments were also approved.

Routine Neutral

2026-05-19 21:14

New Filing detected. See link for details.

Financials Negative

2026-05-19 21:07

CRITICAL RED FLAG DETECTED

Standalone Revenue ₹13,914Mn vs ₹16,482Mn (▼15.6% YoY), EBITDA ₹3,852Mn vs ₹5,039Mn (▼23.6% YoY), PAT ₹1,978Mn vs ₹3,858Mn (▼48.7% YoY). EBITDA Margin 27.7% vs 30.6% (▼290bps). The Board also declared a final dividend of ₹10/- per share, totaling ₹15/- for FY26. Mr. Rajnish Sarna resigned as Joint Managing Director but was re-designated as a Non-Executive, Non-Independent Director, while Mr. Arvind Singhal (Non-Executive, Non-Independent Director) will not seek re-appointment. The Company recognized an impairment loss of ₹1,100Mn on a subsidiary's equity investment due to business losses.

Financials Neutral

2026-05-12 17:13

PI Industries Limited has scheduled an Earnings Conference Call with Analysts/Investors on Wednesday, May 20, 2026, at 03:00 PM (IST). This call will follow the announcement of the Audited Financial Results for the quarter and financial year ended March 31, 2026, and will include a management discussion on Q4 FY26 results and a Q&A session.

Routine Neutral

2026-03-24 17:18

PI Industries Limited announced the closure of its trading window from April 1, 2026, for designated persons and their relatives, until 48 hours after the declaration of financial results for the quarter and year ending March 31, 2026.

Business Update Neutral

2026-03-23 17:43

PI Industries Limited announced an interaction with Quest Investment Managers on March 27, 2026, in a One-on-One meeting in Mumbai. The company stated that no unpublished price sensitive information is proposed to be shared during the meeting.

Business Update Neutral

2026-03-18 16:22

PI Industries Limited will hold one-on-one interactions with HDFC Mutual Fund (Mar 23), Bajaj Mutual Fund (Mar 24), and Canara Robeco Mutual Fund (Mar 25) in Mumbai. No unpublished price sensitive information is proposed to be shared during these meetings.

Business Update Neutral

2026-03-18 16:20

PI Industries Limited will interact with HDFC Mutual Fund, Bajaj Mutual Fund, and Canara Robeco Mutual Fund in one-on-one meetings from March 23-25, 2026, in Mumbai. No unpublished price sensitive information will be shared.

Business Update Neutral

2026-03-18 16:19

PI Industries Limited will hold one-on-one interactions with HDFC, Bajaj, and Canara Robeco Mutual Funds from March 23-25, 2026, in Mumbai. No unpublished price sensitive information is planned for sharing.

Business Update Neutral

2026-03-11 17:37

PI Industries Limited will hold one-on-one interactions with Motilal Oswal Financial Services on March 16, 2026, and Narotam Sekhsaria Family Office on March 17, 2026, in Mumbai. No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-03-11 17:34

PI Industries Limited will interact with Motilal Oswal Financial Services and Narotam Sekhsaria Family Office on March 16 and 17, 2026, respectively, in Mumbai. No unpublished price sensitive information will be shared during these one-on-one meetings.

Business Update Neutral

2026-03-04 15:41

PI Industries Limited will interact in a one-on-one meeting with India Capital Growth Fund on March 09, 2026, in Mumbai, as per SEBI (LODR) Regulation 30(6). No unpublished price sensitive information will be shared during the meeting.

Business Update Neutral

2026-02-26 16:51

PI Industries Limited will interact with Aditya Birla Sun Life Insurance in a one-on-one meeting on March 04, 2026, in Mumbai. No unpublished price sensitive information is proposed to be shared during the interaction.

Business Update Neutral

2026-02-24 18:14

PI Industries Limited will interact with Equirus Securities on February 27, 2026, in a one-on-one meeting in Mumbai. No unpublished price sensitive information will be shared during the meeting.

Financials Positive

2026-02-20 18:46

PI Industries reported Q3 FY26 revenue of INR 13,757 million with gross margin at 59%. Pharma business saw 50% YoY growth for 9M. Facing AgChem downcycle, PI commercialized 5 new molecules and expects recovery from Q4 FY26, supported by a strong balance sheet.

Business Update Neutral

2026-02-20 17:49

PI Industries Limited announced investor interactions with Matthews Asia on February 27, 2026, and Optimas Capital on March 04, 2026, under SEBI (LODR) Regulations 30(6). The company stated no unpublished price sensitive information would be shared.

Business Update Neutral

2026-02-20 17:48

PI Industries Limited announced upcoming one-on-one interactions with Matthews Asia on February 27, 2026, and Optimas Capital on March 04, 2026, to discuss business updates, as per SEBI LODR Regulation 30(6).

Business Update Neutral

2026-02-18 17:04

PI Industries Limited will interact with Taksh Asset Management, ITUS Capital, and Axis Mutual Fund in one-on-one meetings on February 23, 2026. The company stated no unpublished price sensitive information will be shared.

Business Update Neutral

2026-02-18 17:03

PI Industries Limited will interact with Taksh Asset Management, ITUS Capital, and Axis Mutual Fund via one-on-one meetings on February 23, 2026. No unpublished price sensitive information will be shared during these interactions.

Business Update Neutral

2026-02-18 17:00

PI Industries Limited will hold one-on-one interactions with Taksh Asset Management, ITUS Capital, and Axis Mutual Fund on February 23, 2026. No unpublished price sensitive information will be shared during these meetings.

Routine Neutral

2026-02-13 12:18

New Filing detected. See link for details.

Routine Neutral

2026-02-12 22:29

New Filing detected. See link for details.

Routine Neutral

2026-02-12 21:20

New Filing detected. See link for details.

Financials Negative

2026-02-12 19:06

Consolidated Revenue ₹1,376 Cr vs ₹1,901 Cr (▼28% YoY), EBITDA ₹303 Cr vs ₹512 Cr (▼41% YoY), PAT ₹311 Cr vs ₹373 Cr (▼17% YoY). EBITDA Margin 22% vs 27% (▼500bps).

Financials Negative

2026-02-12 19:05

Consolidated Revenue ₹1,375.7Cr vs ₹1,900.8Cr (▼27.6% YoY), EBITDA ₹369.4Cr vs ₹588.1Cr (▼37.2% YoY), PAT ₹311.3Cr vs ₹372.7Cr (▼16.5% YoY). EBITDA Margin 26.8% vs 30.9% (▼409bps). An interim dividend of ₹5 per share was also declared.

Financials Negative

2026-02-12 19:02

Consolidated Revenue ₹1,375.7Cr vs ₹1,900.8Cr (▼28% YoY), EBITDA ₹302.7Cr vs ₹512.2Cr (▼41% YoY), PAT ₹311.3Cr vs ₹372.7Cr (▼16% YoY). EBITDA Margin contracted from 27% to 22% (▼500bps). An interim dividend of ₹5 per share was also declared.

Business Update Neutral

2026-02-05 23:35

PI Industries Limited announced an Earnings Conference Call with Analysts/Investors on Friday, February 13, 2026, at 09:30 AM (IST) to discuss the unaudited financial results for the quarter and nine months ended December 31, 2025.

Business Update Positive

2026-01-29 19:14

PI Industries Limited unveiled a new corporate logo on January 29, 2026. The change signifies the company's evolution from an agri-sciences foundation to a globally integrated life sciences organization, encompassing biologicals, pharmaceuticals, and complex chemistry-driven solutions, reflecting its future-ready vision.

Business Update Neutral

2026-01-19 17:58

PI Industries Limited has adopted a new corporate logo as part of a brand identity refresh, which does not alter the company's name, legal status, or business operations. The new logo will be adopted in a phased manner across all corporate communications and materials.

Governance Neutral

2026-01-19 16:50

Ms. Kamali Rajesh is appointed as Global Chief People Officer (CPO), replacing Mr. Balasubramaniam Aiyaswamy, effective January 19, 2026. Ms. Rajesh brings over 25 years of global HR leadership experience from companies like Syngenta Group and Ford Motor Company.

Governance Neutral

2026-01-19 16:41

PI Industries Limited announced the appointment of Ms. Kamali Rajesh as the new Global Chief People Officer (CPO), designated as Senior Management Personnel, with effect from January 19, 2026. Concurrently, Mr. Balasubramaniam Aiyaswamy will cease to be the CPO. Ms. Rajesh brings over 25 years of global HR leadership experience.

PIIND

PI Industries Limited

Price Chart

Filing History

Unlock Full History